Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers.
Lu Y, Gao J, Hou Y, Yang H, Wang D, Zhang G, Qin Z, Du P, Wang Z, Wang Y, Chen Q, Sun Z, Li P, Zhang J, Tang J.
Lu Y, et al. Among authors: qin z.
J Immunother Cancer. 2025 Jan 7;13(1):e010127. doi: 10.1136/jitc-2024-010127.
J Immunother Cancer. 2025.
PMID: 39773567